Vicus Capital’s Inspire Corporate Bond ETF IBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.03M Buy
84,925
+1,576
+2% +$38K 0.15% 74
2025
Q4
$2.02M Buy
83,349
+3,491
+4% +$84.4K 0.15% 76
2025
Q3
$1.93M Buy
79,858
+1,851
+2% +$44.5K 0.15% 80
2025
Q2
$1.87M Buy
78,007
+3,035
+4% +$72K 0.16% 67
2025
Q1
$1.78M Buy
74,972
+792
+1% +$18.7K 0.17% 68
2024
Q4
$1.74M Buy
74,180
+5,050
+7% +$120K 0.15% 68
2024
Q3
$1.66M Buy
69,130
+7,577
+12% +$181K 0.15% 71
2024
Q2
$1.44M Buy
61,553
+3,377
+6% +$78.7K 0.13% 82
2024
Q1
$1.37M Buy
58,176
+1,602
+3% +$37.7K 0.12% 81
2023
Q4
$1.33M Buy
56,574
+904
+2% +$20.7K 0.14% 79
2023
Q3
$1.26M Buy
55,670
+8,028
+17% +$184K 0.13% 77
2023
Q2
$1.1M Buy
47,642
+14,433
+43% +$336K 0.11% 84
2023
Q1
$777K Buy
+33,209
New +$771K 0.08% 101

Other funds holding IBD

Vicus Capital's IBD Position: Q1 2026 in Review

Vicus Capital increased its Inspire Corporate Bond ETF (IBD) stake by 1.9% in Q1 2026, buying an estimated $38K and bringing the position to 84,925 shares worth $2.03M. The position accounts for 0.15% of the portfolio, ranked #74.

Vicus Capital first reported a position in IBD in Q1 2023 and has held it in 13 quarters since. 106 funds tracked by Wall St. Rank hold IBD as of Q1 2026.

  • Vicus Capital held 84,925 shares of Inspire Corporate Bond ETF worth $2.03M as of Q1 2026.
  • Vicus Capital bought 1,576 Inspire Corporate Bond ETF shares in Q1 2026, an estimated $38K.
  • Inspire Corporate Bond ETF made up 0.15% of Vicus Capital's portfolio in Q1 2026, its #74 holding.
  • Vicus Capital first reported a position in Inspire Corporate Bond ETF in Q1 2023 and has held it in 13 quarters since.
  • 106 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q1 2026.

Based on Vicus Capital's 13F filing for Q1 2026, filed 22 Apr 2026.